Literature DB >> 16475697

Acridine orange used for photodynamic therapy accumulates in malignant musculoskeletal tumors depending on pH gradient.

Takao Matsubara1, Katsuyuki Kusuzaki, Akihiko Matsumine, Ken Shintani, Haruhiko Satonaka, Atsumasa Uchida.   

Abstract

BACKGROUND: Intra-operative photodynamic therapy has been applied with acridine orange (AO-PDT) to human musculoskeletal sarcomas for the past 4 years, resulting in a low local recurrence rate, within 10%, after intra-marginal tumor resection and excellent limb function. However, it is still unclear why acridine orange (AO) specifically accumulates in tumor cells, especially in malignant tumor cells. The purpose of this study was to clarify the mechanism of AO accumulation in malignant musculoskeletal tumors.
MATERIALS AND METHODS: Sixty-two musculoskeletal tumors, including 35 malignant and 27 benign tumors, were studied. Using freshly resected tumor material, the extracellular pH (pHe) was measured and the fluorescence intensity of AO accumulated in the tumors was measured by an image analyzer after ex vivo exposure to 1.0 microg/ml AO, followed by blue excitation. In the in vitro study, bafilomycin A1 was exposed to LM 8 mouse osteosarcoma cells, in order to inhibit V-ATPase, subsequently causing a decrease in the pHgradient (deltapH) between the intracellular pH (pHi) and extracellular pH (pHe) or between the pHi and the pHe. AO accumulation and the cytocidal effect of AO were evaluated.
RESULTS: The results of the in vivo study, using human materials freshly resected at surgery, revealed that the pHe of the malignant musculoskeletal tumors was significantly lower than that of the benign tumors and normal muscles or adipose tissues and also showed that the AO fluorescence intensity of the malignant musculoskeletal tumors was significantly stronger than that of the benign tumors and normal muscles or adipose tissues. The results also revealed that the AO fluorescence intensity negatively correlated with the pHe in tumors and normal tissues. The in vitro study showed that bafilomycin A1 inhibited the accumulation of AO in acidic organelles, such as lysosomes, and that the cytocidal effect of AO-PDT was also remarkably inhibited. DISCUSSION: Based on results of the in vivo and in vitro studies, it is suggested that malignant musculoskeletal tumors have a large deltapH between the pHi and the pHe or between the pHi and the vaculolar pH and also that a large ApH increases AO accumulation in tumors. We, therefore, believe that AO-PDT may be more effective in highly malignant musculoskeletal tumors than low grade ones, because of their acidity.
CONCLUSION: AO accumulation in musculoskeletal tumors was dependent on the ApH between the pHi and the pHe, or between the pHi and the vacuolar pH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16475697

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

1.  In vivo anti-tumor activity of photodynamic therapy with intravenous administration of acridine orange, followed by illumination with high-power flash wave light in a mouse osteosarcoma model.

Authors:  Haruhiko Satonaka; Katsuyuki Kusuzaki; Takao Matsubara; Ken Shintani; Tomoki Nakamura; Akihiko Matsumine; Takahiro Iino; Atsumasa Uchida
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

2.  Can a less radical surgery using photodynamic therapy with acridine orange be equal to a wide-margin resection?

Authors:  Takao Matsubara; Katsuyuki Kusuzaki; Akihiko Matsumine; Tomoki Nakamura; Akihiro Sudo
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

3.  Impact of Acridine Orange in Patients With Local Recurrent Soft Tissue Sarcoma.

Authors:  Hiroyuki Tsuchie; Makoto Emori; Naohisa Miyakoshi; Kyoji Okada; Hiroyuki Nagasawa; Yasutaka Murahashi; Emi Mizushima; Junya Shimizu; Toshihiko Yamashita; Yoichi Shimada
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

4.  Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.

Authors:  Enrico P Spugnini; Alfonso Baldi; Sabrina Buglioni; Francesca Carocci; Giulia Milesi de Bazzichini; Gianluca Betti; Ilaria Pantaleo; Francesco Menicagli; Gennaro Citro; Stefano Fais
Journal:  J Transl Med       Date:  2011-12-28       Impact factor: 5.531

Review 5.  Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy.

Authors:  Stefano Fais; Giulietta Venturi; Bob Gatenby
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

6.  Acridine Orange/exosomes increase the delivery and the effectiveness of Acridine Orange in human melanoma cells: A new prototype for theranostics of tumors.

Authors:  Elisabetta Iessi; Mariantonia Logozzi; Luana Lugini; Tommaso Azzarito; Cristina Federici; Enrico Pierluigi Spugnini; Davide Mizzoni; Rossella Di Raimo; Daniela F Angelini; Luca Battistini; Serena Cecchetti; Stefano Fais
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 7.  Acridine Orange: A Review of Novel Applications for Surgical Cancer Imaging and Therapy.

Authors:  Vadim A Byvaltsev; Liudmila A Bardonova; Naomi R Onaka; Roman A Polkin; Sergey V Ochkal; Valerij V Shepelev; Marat A Aliyev; Alexander A Potapov
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

8.  Additive Influence of Extracellular pH, Oxygen Tension, and Pressure on Invasiveness and Survival of Human Osteosarcoma Cells.

Authors:  Takao Matsubara; Gene R Diresta; Shigeki Kakunaga; Dasen Li; John H Healey
Journal:  Front Oncol       Date:  2013-07-29       Impact factor: 6.244

9.  Progress of photodynamic therapy applications in the treatment of musculoskeletal sarcoma (Review).

Authors:  Xianghong Zhang; Tang Liu; Zhihong Li; Xiangsheng Zhang
Journal:  Oncol Lett       Date:  2014-07-09       Impact factor: 2.967

10.  Acridine orange exhibits photodamage in human bladder cancer cells under blue light exposure.

Authors:  Yi-Chia Lin; Ji-Fan Lin; Te-Fu Tsai; Hung-En Chen; Kuang-Yu Chou; Shan-Che Yang; Ya-Ming Tang; Thomas I-Sheng Hwang
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.